Fortrea Holdings Inc. Common Stock (FTRE) Stock Price
FTREStock
$18.81+94.92%52W
Market Cap$1.79B
P/E—
PEG Ratio0.34
Div yield—
Beta1.98
FTRE Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)70.34%
Price vs S&P 500 (4W)-2.23%
PEG Ratio0.34
VGM Score52.98
FTRE Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | $0.18 | $0.23 | +27.18%(+$0.05) | |
| Q1 2026 | $0.05 | $0.16 | +211.89%(+$0.11) | |
| Q4 2025 | $0.16 | $0.09 | -43.78%(-$0.07) | |
| Q3 2025 | $0.16 | $0.12 | -25.71%(-$0.04) | |
| Q2 2025 | $0.08 | $0.19 | +152.46%(+$0.11) |
FTRE Analyst Recommendations
May 2026
Jun 2026
Jul 2026
Aug 2026
3.76
3.76
3.76
3.76
Industry Peers — Health Services(30)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
FTREFortrea Holdings Inc. Common Stock | B | F | A | $18.81 |
| NTRANatera, Inc. Common Stock | F | A | B | $326.26 |
| LHLabcorp Holdings Inc. | C | D | B | $335.11 |
| DGXQuest Diagnostics Inc. | C | D | B | $242.76 |
| GHGuardant Health, Inc. Common Stock | F | A | B | $161.50 |
| CAICaris Life Sciences, Inc. Common Stock | F | A | C | $25.63 |
| RDNTRadNet, Inc. Common Stock | D | C | B | $74.61 |
| BLLNBillionToOne, Inc. Class A Common Stock | F | F | D | $93.24 |
| CELCCelcuity Inc. Common Stock | — | — | C | $88.44 |
| GRALGRAIL, Inc. Common Stock | D | A | B | $80.00 |
| VCYTVeracyte, Inc. | D | A | C | $43.34 |
About Fortrea Holdings Inc. Common Stock
Fortrea is a global contract research organization providing comprehensive clinical trial management, pharmacology, and patient access solutions for biopharma, medical device, and diagnostic companies. The company offers flexible engagement models ranging from functional services to full-service trial management. Spun off from Labcorp in 2023, Fortrea operates as an independent public company with approximately 19,000 employees across 90 countries.